Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $8.8 million.

  • Tonix Pharmaceuticals Holding's Shares Outstanding (Weighted Average) rose 3883.74% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 3883.74%. This contributed to the annual value of $1.9 million for FY2024, which is 24976.37% up from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Shares Outstanding (Weighted Average) stood at $8.8 million, which was up 19.68% from $7.3 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's 5-year Shares Outstanding (Weighted Average) high stood at $8.8 million for Q3 2025, and its period low was $3,231 during Q1 2023.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Shares Outstanding (Weighted Average) value was $29,857 (recorded in 2024), while the average stood at $2.2 million.
  • Data for Tonix Pharmaceuticals Holding's Shares Outstanding (Weighted Average) shows a peak YoY surged of 86,239.47% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's Shares Outstanding (Weighted Average) stood at $7,453 in 2023, then surged by 24,976.37% to $1.9 million in 2024, then soared by 3,883.74% to $8.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $8.8 million for Q3 2025, versus $7.3 million for Q2 2025 and $6.4 million for Q1 2025.